UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020329
Receipt number R000023477
Scientific Title Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis
Date of disclosure of the study information 2016/01/25
Last modified on 2017/06/20 18:04:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis

Acronym

RemIRIT

Scientific Title

Remission induction with rituximab in Japanese patients with ANCA-associated vascutlitis

Scientific Title:Acronym

RemIRIT

Region

Japan


Condition

Condition

ANCA-associated vasculitis

Classification by specialty

Medicine in general Pneumology Nephrology
Neurology Clinical immunology Ophthalmology
Dermatology Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effectiveness of AAV patients treated with rituximab

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

remission rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

MPA and GPA patient treated with rituximab

Key exclusion criteria

patient lower than 20 years-old

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihiro Arimura

Organization

Kyorin university

Division name

Dept. of Nephrology and Rheumatology

Zip code


Address

6-20-2, Shinkawa, Mitaka-city

TEL

0422-47-5511

Email

amed-vas@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenji Nagasaka

Organization

Tokyo Medical and Dental University

Division name

Dept. of Pharmacovigilance

Zip code


Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

03-5803-4677

Homepage URL


Email

nagasaka.phv@tmd.ac.jp


Sponsor or person

Institute

The strategic study group to establish evidences for the treatment guidelines of intractable vasculitis

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 06 Month 18 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cohort study


Management information

Registered date

2015 Year 12 Month 24 Day

Last modified on

2017 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023477


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name